Ilex Medical Past Earnings Performance
Past criteria checks 2/6
Ilex Medical has been growing earnings at an average annual rate of 8.7%, while the Healthcare industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 8.2% per year. Ilex Medical's return on equity is 8.2%, and it has net margins of 5.5%.
Key information
8.7%
Earnings growth rate
6.5%
EPS growth rate
| Healthcare Industry Growth | 14.9% |
| Revenue growth rate | 8.2% |
| Return on equity | 8.2% |
| Net Margin | 5.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Ilex Medical Ltd (TLV:ILX) Investors Are Less Pessimistic Than Expected
Jan 02
Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Feb 13The Trend Of High Returns At Ilex Medical (TLV:ILX) Has Us Very Interested
Nov 25Returns On Capital Are A Standout For Ilex Medical (TLV:ILX)
Jun 03Here's Why We Think Ilex Medical (TLV:ILX) Is Well Worth Watching
May 04Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Apr 02Is It Smart To Buy Ilex Medical Ltd (TLV:ILX) Before It Goes Ex-Dividend?
Mar 20Ilex Medical (TLV:ILX): Are Investors Overlooking Returns On Capital?
Mar 02Are Robust Financials Driving The Recent Rally In Ilex Medical Ltd's (TLV:ILX) Stock?
Feb 16
What Type Of Shareholders Make Up Ilex Medical Ltd's (TLV:ILX) Share Registry?
Feb 04Here's Why I Think Ilex Medical (TLV:ILX) Is An Interesting Stock
Jan 24Shareholders of Ilex Medical (TLV:ILX) Must Be Delighted With Their 333% Total Return
Jan 11Ilex Medical (TLV:ILX) Has A Rock Solid Balance Sheet
Dec 23What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?
Nov 28Revenue & Expenses BreakdownBeta
How Ilex Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 931 | 51 | 149 | 10 |
| 30 Sep 23 | 880 | 67 | 146 | 9 |
| 30 Jun 23 | 858 | 77 | 144 | 9 |
| 31 Mar 23 | 829 | 66 | 143 | 9 |
| 31 Dec 22 | 873 | 102 | 139 | 9 |
| 30 Sep 22 | 895 | 107 | 135 | 9 |
| 30 Jun 22 | 1,005 | 172 | 134 | 9 |
| 31 Mar 22 | 1,031 | 203 | 130 | 9 |
| 31 Dec 21 | 1,061 | 197 | 127 | 8 |
| 30 Sep 21 | 1,077 | 185 | 125 | 8 |
| 30 Jun 21 | 1,065 | 150 | 122 | 8 |
| 31 Mar 21 | 1,059 | 146 | 119 | 8 |
| 31 Dec 20 | 946 | 121 | 118 | 8 |
| 30 Sep 20 | 843 | 101 | 116 | 8 |
| 30 Jun 20 | 704 | 71 | 114 | 8 |
| 31 Mar 20 | 659 | 61 | 113 | 8 |
| 31 Dec 19 | 634 | 60 | 112 | 8 |
| 30 Sep 19 | 645 | 64 | 110 | 8 |
| 30 Jun 19 | 632 | 57 | 107 | 8 |
| 31 Mar 19 | 613 | 53 | 106 | 8 |
| 31 Dec 18 | 601 | 47 | 103 | 8 |
| 30 Sep 18 | 561 | 39 | 100 | 7 |
| 30 Jun 18 | 558 | 36 | 98 | 7 |
| 31 Mar 18 | 551 | 34 | 95 | 7 |
| 31 Dec 17 | 554 | 37 | 92 | 7 |
| 30 Sep 17 | 545 | 36 | 90 | 7 |
| 30 Jun 17 | 535 | 36 | 89 | 7 |
| 31 Mar 17 | 536 | 32 | 90 | 7 |
| 31 Dec 16 | 519 | 28 | 91 | 8 |
| 30 Sep 16 | 527 | 27 | 94 | 8 |
| 30 Jun 16 | 512 | 25 | 93 | 7 |
| 31 Mar 16 | 497 | 27 | 92 | 7 |
| 31 Dec 15 | 497 | 31 | 91 | 7 |
| 30 Sep 15 | 478 | 23 | 104 | 7 |
| 30 Jun 15 | 464 | 32 | 89 | 7 |
| 31 Mar 15 | 452 | 30 | 88 | 7 |
| 31 Dec 14 | 433 | 22 | 89 | 6 |
| 30 Sep 14 | 443 | -12 | 75 | 7 |
| 30 Jun 14 | 448 | -24 | 89 | 6 |
| 31 Mar 14 | 453 | -26 | 91 | 6 |
| 31 Dec 13 | 461 | -22 | 90 | 6 |
| 30 Sep 13 | 450 | -14 | 87 | 5 |
| 30 Jun 13 | 455 | -20 | 89 | 5 |
Quality Earnings: ILX has high quality earnings.
Growing Profit Margin: ILX's current net profit margins (5.5%) are lower than last year (11.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ILX's earnings have grown by 8.7% per year over the past 5 years.
Accelerating Growth: ILX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ILX had negative earnings growth (-50.2%) over the past year, making it difficult to compare to the Healthcare industry average (3.2%).
Return on Equity
High ROE: ILX's Return on Equity (8.2%) is considered low.